In Study A, women receiving PT-141 three times daily for 15 days exhibited significantly greater body weight reduction compared to placebo (1.3 kg difference) with high statistical significance
No lethal dose was established, suggesting a wide safety margin
The best cycling strategy depends on research objectives, with some protocols using consistent cycle lengths while others adjust based on response and tolerability
That is true with any aggressive caloric deficit, including the one retatrutide creates
Accessed October 8, 2024
On the same date, Julian Gill also requested case numbers for all adverse events in the FAERS system related to tirzepatide and semaglutide products produced by Empower Pharmacy in Houston, Texas (both the 503A and 503B products). Noa Metta submitted on September 24 a request for FDA Form 483 inspection reports, warning letters, Establishment Inspection Reports, and adverse event reports relating to pharmacies conducting unauthorized compounding practices, involving semaglutide, tirzepatide, or similar drugs, between January 1, 2022, and the present. Several additional requests addressed non-compounding issues related to GLP-1 drugs, two mentioning Eli Lilly and one mentioning Ozempic and Wegovy